Skip to main content
Jason Miller, MD, Ophthalmology, Ann Arbor, MI

JasonMatthewMillerMDPhD

Ophthalmology Ann Arbor, MI

Retinal Disease

Assistant Professor, Kellogg Eye Center, University of Michigan

Dr. Miller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Miller's full profile

Already have an account?

  • Office

    1000 Wall St
    Ann Arbor, MI 48105
    Phone+1 734-764-4190

Summary

  • Dr. Jason Miller is a medical retina specialist and bench physician-scientist in Ann Arbor, MI. He received his MD/PhD from University of California (San Francisco) School of Medicine. He specializes in retinal disease with a particular focus on macular degeneration. His lab is focused on RPE cell biology as it related to dry age-related macular degeneration. He has a clinical ancillary interest in neuro-ophthalmology and retinal/neuro-ophthalmology overlap cases.

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Surgical Retina and Vitreous, 2019 - 2021
  • University of Michigan Health System
    University of Michigan Health SystemResidency, Ophthalmology, 2016 - 2019
  • University of Michigan Medical Center
    University of Michigan Medical CenterPost-Doctoral Fellowship, 2013 - 2016
  • Kaiser Permanente Northern California (Oakland)
    Kaiser Permanente Northern California (Oakland)Internship, Internal Medicine, 2012 - 2013
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 2012

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2019 - 2026
  • American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • New Geographic Atrophy Drugs: The Good, the Bad, and the Unknown
    New Geographic Atrophy Drugs: The Good, the Bad, and the UnknownMay 13th, 2024
  • Week in Review: Dry AMD Research, Injection Safety Protocols, Glaucoma Patients Favor Teleophthalmology
    Week in Review: Dry AMD Research, Injection Safety Protocols, Glaucoma Patients Favor TeleophthalmologyApril 22nd, 2022